ALLIEVA PHARMA PRIVATE LIMITED, a leading oncology medicine supplier and pharmaceutical exporter from India, proudly participated in Arab Health 2026 in Dubai.
By Chandan Kumar | Feb. 16, 2026
At Arab Health 2026, our team introduced a wide range of high-quality oncology medicines including:
• Chemotherapy injections
• Targeted therapy medicines
• Hormonal cancer treatments
• Oncology injectable formulations
• Critical care pharmaceutical products
Our portfolio includes widely demanded oncology molecules such as Methotrexate Injection, Doxorubicin Injection, Azacitidine Injection, Carboplatin Injection, Cisplatin Injection, Oxaliplatin Injection, and various other anti-cancer medicines.
As a trusted pharmaceutical distributor and exporter, we focus on delivering WHO-GMP quality medicines with reliable global supply chains.
Participation in Arab Health strengthened our position as a growing oncology pharmaceutical exporter from India. We connected with:
• International pharmaceutical distributors
• Oncology medicine importers
• Hospital procurement teams
• Healthcare supply chain companies
The event created new opportunities in Middle East, Africa, and other international markets looking for affordable and high-quality cancer treatment medicines.
At ALLIEVA PHARMA PRIVATE LIMITED, our mission is to improve global access to life-saving oncology medicines. We are committed to:
• Supplying affordable anti-cancer medicines
• Ensuring consistent product quality
• Maintaining regulatory compliance
• Supporting global healthcare partners
Our participation at Arab Health 2026 reflects our dedication to expanding access to advanced oncology treatments worldwide.
If you are looking for a reliable oncology injection supplier or pharmaceutical export partner from India, connect with ALLIEVA PHARMA PRIVATE LIMITED to explore business opportunities.
Contact us today to discuss distribution and bulk supply inquiries.
